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Inequalities in health according to social conditions are regarded as unnecessary and
unjust. There is a large body of evidence on inequalities in adult cancer, observable
throughout the societies on a national level as well as on a global scale. Socioeconomic
influences on health matter at all ages including childhood, for which childhood
cancer is the leading cause of disease related death in high-income countries (HICs).
Substantial differences in the reported incidence of childhood cancers have been
observed globally by socioeconomic development of a population. This is reflected in the
higher incidence rates reported for HICs, particularly for acute lymphoblastic leukemia,
and for cancer in infants (below 1 year), compared to low- and middle-income countries
(LMICs). Considerable inequalities between populations and degree of socioeconomic
development are also noted for survival from childhood cancer, with substantially lower
survival rates seen in most LMICs compared to HICs. With respect to inequalities
by socioeconomic position (SEP) within countries, findings of an association between
SEP and childhood cancer risk are diverse and limited to studies from HICs. On the
contrary, observations on social inequalities in survival within countries are accumulating
and indicate that survival inequalities do not only concern resource-poor countries but
also high-income populations including European countries. In turn, a childhood cancer
diagnosis in itself may have implications on the parents’ socioeconomic situation as
well as on the later socioeconomic life after having survived the disease. The underlying
mechanisms and causal pathways of these empirically demonstrated social inequalities
are poorly understood, although it is of significant public health relevance for any actions
or strategies to reduce childhood cancer-related inequity. We propose a conceptual
framework on potential underlying mechanism and pathways specifically addressing
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social inequalities in childhood cancer and after childhood cancer to (i) illustrate potential
pathways by which social determinants may create health inequities at different points of
the childhood cancer continuum; (ii) illustrate potential pathways by which a childhood
cancer diagnosis may impact the socioeconomic situation of the concerned family or
the later life of a childhood survivor; and (iii) point out how major determinants may relate
to each other.
Keywords: childhood cancer, social inequalities, conceptual framework, pathways and underlying mechanisms,
social determinants, incidence, survival, survivors
INTRODUCTION
There is a large body of evidence on inequalities in health
including non-communicable diseases such as cancer, indicating
that social inequalities affect cancer incidence, survival and
mortality on a regional, national, and global level (1–5). Patterns
of striking social inequalities in cancer incidence and survival
are observable throughout the societies on a national level as
well as on a global scale between countries differentiated by
level of socioeconomic development (1, 6, 7). The World Health
Organization’s (WHO) Commission on Social Determinants of
Health understands health inequities as inequalities in health that
are socially produced, systematic in their distribution across the
population or between populations, and unnecessary and unjust
(8) and subsequently stated: “Social injustice is killing people on
a grand scale” (9).
Socioeconomic influences on health matter at all ages
including childhood, for which childhood cancer is one of the
most dreaded diseases and the leading cause of disease-related
deaths among children 1–15 years in high-income countries
(HICs) (10). The Commission on Social Determinants of Health
calls for global action on the social determinants of health
to reduce health inequity between and within countries and
stresses the importance to put major emphasis on early child
development and promote health equity from the start of life
(9). An essential basis for any action or strategies to reduce
cancer-related health inequity is a profound understanding of
the underlying mechanisms leading to these social inequalities.
While mechanisms and pathways of social inequalities in cancer
have been extensively studied in adults, this does not hold true for
childhood cancer. Childhood cancer is a heterogeneous group of
malignancies with different patterns of etiology (11), incidence
(12), anticancer therapy, supportive care, survival rates (13) and
late effects (14, 15), and it is therefore likely that patterns of
social inequalities as well as their underlying mechanisms not
only differ from those in adult cancer but also vary between types
of childhood cancer.
The overall aim of this paper was to deliberate on the
underlying mechanisms and pathways of social inequalities in
relation to childhood cancer, understanding social inequalities in
childhood cancer in a most comprehensive way by considering
the entire course of childhood cancer from occurrence, diagnosis,
morbidity, survival, and consequences for affected patients
and their families, treated as a continuum—“the childhood
cancer continuum,” and taking a global perspective including
inequalities within societies on a national level as well as
between countries on a global scale. At first we introduce into
the matter by giving a narrative and critical overview of the
current empirical knowledge on social inequalities in childhood
cancer. Subsequently, we propose a conceptual framework of
potential mechanisms and pathways of social inequity along the
childhood cancer continuum linking social determinants with
(health) inequity along the childhood cancer continuum and
illustrate pathways of socioeconomic consequences for childhood
cancer patients and their families, with the ultimate aim to help
directing scientific research and identify potential targets for
future interventions and policy strategies to reduce childhood
cancer-related inequity.
When summarizing the current empirical observations on
social inequalities in childhood cancer, the unprejudiced term
“inequalities” is used. However, following the Commission on
Social Determinants of Health (8) we use the judgmental terms
equity and inequity for the presentation of our conceptual model
as we regard the social inequalities in childhood cancer as
unfair and to highlight the normative dimension of empirically
demonstrated inequalities (16).
OVERVIEW OF EMPIRICAL
OBSERVATIONS ON SOCIAL
INEQUALITIES IN CHILDHOOD CANCER
Inequalities in Childhood Cancer Between
Countries
Patterns of Childhood Cancer Incidence
Population-based cancer registries around the world report
overall incidence rates for childhood cancer (cancer in children
aged 0–14 years) that vary by a factor of about four, between
less than 60 to more than 200 per million per year (12,
17). The socioeconomic development of a population seems
to be associated with the reported incidence of childhood
cancer in the respective country (18, 19). This is reflected
in the higher incidence rates reported for HICs, particularly
for acute lymphoblastic leukemia, the most common cancer
type in children in HICs (12), and for cancer in infants
(below 1 year), compared to low- and middle-income countries
(LMICs) (12, 18, 20–24). Childhood cancer incidence patterns
are similar and well-described for high-resource countries (12),
with recent age-standardized incidence rates of 155, 176, and
155 per million children being reported for Australia (12), US
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Non-Hispanic Whites (12), and Sweden (12), respectively. In
contrast, high-quality data from LMICs is limited and reported
incidence patterns are diverse. Incidence rates of 140, 97, 46, and
139 per million have been reported for Costa Rica (25), India (12)
South Africa (26), and Kampala in Uganda (12), with substantial
variations in the distribution of cancer types among LMICs and
in comparison to HICs (12) (Figure 1). For example, in Sub-
Saharan Africa, Burkitt lymphoma, Hodgkin lymphoma, Kaposi
sarcoma, or hepatocellular carcinoma are more frequent (12, 17).
On the other hand, in some LMICs, particularly in Sub-Saharan
Africa and parts of Asia where registry data is poor, remarkably
low childhood leukemia rates have been observed (17). In
contrast, incidence rates of acute lymphoblastic leukaemia (ALL)
for some Latin-American countries rank amongst the highest
in the world, while lower incidence rates compared to HICs
are observed for most solid tumors including malignant central
nervous system (CNS) tumors (12, 25). However, estimating and
comparing the incidence of childhood cancer globally is impeded
by a lack of reliable data for a substantial part of LMICs (26–28).
Patterns of Childhood Cancer Survival
Over the past decades, advances in molecular biology, imaging,
and chemotherapy with treatment stratification directed by the
somatic mutations and early response to chemotherapy, better
use of conventional anticancer agents, and improved supportive
care, have led to considerable improvements in cure rates of
childhood cancers (13, 29–31). In HICs, the 5 year survival of
childhood cancer overall has improved from 30% in the 1960s to
more than 80% nowadays (13, 32, 34).
However, not all children benefit from these improvements
and substantial differences in survival rates are seen between
countries. These inequalities are observed within both high-
resource regions such as Europe, with ∼10% poorer survival
in Eastern European countries compared to the rest of Europe
(13), and to a much larger extent in LMICs (34, 35). Similarly
to the incidence of childhood cancer, reliable data on childhood
cancer survival in LMICs is scarce, but suggests considerably
lower survival rates (22, 23, 36, 37) than those observed
in HICs (13, 32–34). Mortality-to-incidence ratios give some
indications of survival rates (Figure 2). Contrary to the reported
incidence, cancer mortality is much higher in resource-poor
regions compared to HICs. For instance, for 2018, childhood
cancer mortality in Asia was estimated as 47 per million children
which represents about 49% of the estimated incidence, while in
North America the mortality/incidence ratio is <13% (estimated
mortality of 21 per million children) (38).
Inequalities in Childhood Cancer Within
Countries
Childhood Cancer Risk
The etiology of most childhood cancers is still poorly understood.
The early age at diagnosis suggests that some childhood cancers
might originate in utero, and that factors prior to birth, including
pre-conceptional or fetal environmental exposures, as well as
those in early childhood may be important risk determinants
(39, 40). A growing body of recent research is directed toward
parental exposure to known environmental carcinogens as
possible risk factors but have hitherto provided inconsistent
results (11, 41). Increasing attention is also given to differences
in risk between socioeconomic groups.
Evidence for the association between parental socioeconomic
position (SEP) and childhood cancer risk derives solely from
HICs and does similarly not provide a consistent picture
(42–50). The relationship with socioeconomic factors has
been most exhaustively studied for leukemia risk (42–50).
Two reviews, summarizing the evidence on socioeconomic
factors and leukemia risk (48, 51), interpreted the evidence as
heterogeneous with negative associations, positive associations
and no associations being observed and studies varying by design,
time period, place, leukemia type and measures of SEP used
(individual, family, ecological). Recently published findings from
Norway showed an association between lower family income
and lymphoid leukemia, while a reverse association was reported
for myeloid leukemia (50). In Minnesota/USA neither maternal
education nor a neighborhood SEP indicator were strongly
associated with childhood cancer including leukemia (52) and
similar results were seen in Switzerland (49).
Little is known about associations with SEP and the risk
of other types of childhood cancer. A large pooled study
from the US found an indication of an association between
lower parental education and a higher risk of both Hodgkin
and Burkitt lymphomas and for Wilms tumor. In contrast,
a possibly protective association of lower parental education
with astrocytoma and hepatoblastoma was demonstrated (44).
Conversely, the Norwegian study (50) found a 70% increased risk
for astrocytomas in the medium income category of the parents
compared to parents with high income. However, this finding was
based on small numbers.
Survival From Childhood Cancer
The evidence on social inequalities in survival in LMICs is
sparse, available data limited and studies are largely regional
within individual countries (53–57), but low SEP was uniformly
associated with inferior survival (56).
In HICs, a large number of studies has been examining
the association between parental SEP and survival from
childhood cancer, particularly during recent years (58). Notably,
socioeconomic inequalities in survival have been even found
in HICs in which children and adolescents have free and
(presumed) equal access to health care services, irrespective of
their SEP (58–65). A study in England, Scotland, and Wales
observed markedly higher ALL survival among more affluent
socioeconomic groups, measured by both area-based deprivation
scores and father’s occupational status (61, 62). A study from
Ireland observed weak trends in survival from ALL in relation
to SEP, but no clear evidence was found for other childhood
cancer types (66). Findings from Greece indicated an association
between parental socio-professional level and ALL, with 40%
worse survival for the offspring of parents with lower socio-
professional level (60). In contrast, a study from West Germany
found no differences in survival from childhood ALL in relation
to parental education or family income (67), similar to findings
for leukemia in a study from Switzerland (65). The Swiss study
observed, however, strong evidence of survival differences among
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FIGURE 1 | Observed age-standardized incidence rates and distribution of cancer types in children, ages 0–14 in selected populations, ordered by degree of
socioeconomic development. Data compiled from the International Incidence of Childhood Cancer, Volume III (12) and cancer register data from Costa Rica (25) and
South Africa (26). Diagnostic groups defined according to the International Classification of Childhood Cancer, including non-malignant intracranial and intraspinal
tumors. Exceptions are the CNS tumor rates of Costa Rica, India, South Africa, and Uganda; these rates do not include non-malignant brain tumors.
*Non-Hispanic Whites.
FIGURE 2 | Estimated age-standardized incidence and mortality rates for cancer in children, ages 0–14 in 2018 based on GLOBOCAN 2018 estimates of cancer
incidence and mortality. Figure compiled from Global Cancer Observatory (38).
children with CNS tumors, with 50% worse survival in children
from less educated families and 30% worse survival in children of
the lowest SEP group of the area-based index (65).
In the Nordic countries, population-based nationwide register
studies (including all childhood cancer types) from Norway,
Sweden and Finland observed a reduced mortality for childhood
cancer cases with highly educated mothers (59, 63, 68). In
Norway, differences were most pronounced for tumors requiring
longer treatment (59), whereas in the Swedish and Finnish
studies, survival differences linked to maternal education were
indicated for both leukemia (ALL and lymphoblastic lymphoma
in the Finnish study) and CNS tumors (63, 68), although
not statistically significant. In contrast, among Danish children
higher maternal education was only associated with better
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survival in children diagnosed with a non-CNS solid tumor (64,
69). An association between lower income and higher mortality
was observed in Finland. This association was at best suggestive
for Denmark, but not found in Sweden and Norway (59, 63, 64,
68). Overall, the specific associations with socioeconomic factors
for specific tumor types are inconsistent and contradictory within
Europe and within the Nordic countries—a setting with similar
welfare systems, longstanding, largely standardized diagnostic,
and treatment procedures for childhood cancers and close
collaboration between pediatric oncologists.
Considering the evidence from outside Europe, findings
from California, a US state with no universal access to health
care, neighborhood SEP was not associated with survival from
childhood leukemia; however, survival rates were lower for
children with no health insurance or an unknown status of
insurance coverage (70).
Altogether, although survival inequalities exist in HICs, most
children with low SEP will still do better than the children with
cancer with higher SEP in resource-poor settings.
Implications for the Socioeconomic
Situation of Parents and Care Givers
Observations from European countries, North America, and
other HICs indicate that having a child with cancer may
considerably affect the parents’ socioeconomic situation. Work
disruptions such as time off work, reducing or entirely leaving
paid employment and corresponding income deteriorations
are highly prevalent among parents of a child with cancer,
particularly concerning mothers (71–77) and occurring shortly
after diagnosis during the child’s active treatment period (72, 76,
78). A study in the US observed that 15% of the families of a
child with advanced cancer fell below the poverty line due to this
specific situation (79). However, the long-term implications and
temporal patterns of such adverse implications on the parental
socioeconomic situation are largely unknown and may strongly
depend on welfare system and social support in the respective
country. The few studies today report conflicting findings
regarding the long-term socioeconomic implications (73, 74, 77,
80). Apart from work- or income-related disruptions, parents
also reported substantial medical and non-medical expenses that
additionally contribute to the parents’ and families’ economic
consequences (81).
Although the scientific knowledge for LMICs is sparse and
depending on the welfare system including access to and
organization (including funding) of health care services in the
respective setting, the socioeconomic implications of childhood
cancer for the parents and family are assumed to be substantial in
recourse-poor setting (82–84).
Inequalities in Childhood Cancer Survivors
As a result of improving survival rates, the number of
childhood cancer survivors increases continuously. According to
predictions for the United States the prevalence of childhood
cancer survivors is supposed to approach 500,000 by 2020 for this
country alone (85). Whereas, somatic late effects attributable to
cancer or its treatment have been addressed in numerous studies
(86–89), less is known about the socioeconomic conditions in
long-term childhood cancer survivors. A recent, wide-ranging
systematic review points out that childhood cancer survivors
are at increased risk of adverse socioeconomic outcomes with
respect to attendance of special education or learning disability
programs, school performance, highest attained education,
income level and uptake of social security benefits (90).
Several population-based studies observed a lower educational
attainment in childhood cancer survivors compared to the
general population (91–93), although findings from Switzerland
rather suggest a delay in educational achievement than a
permanent difference (94).
The evidence on employment status and occupational class in
childhood cancer survivors is not as consistent. Two systematic
reviews and meta-analyses particularly focusing on work life
and employment situation revealed that survivors were 1.5–
2 times more likely to be unemployed than people who
did not suffer from cancer during their childhood (95, 96).
Mader et al. observed considerable differences across regions
and cancer types; particularly survivors from the US and
Canada and survivors of CNS tumors were more likely to be
unemployed (96). Looking at the individual studies, findings
from the US indicated that survivors of childhood cancer were
at increased risk for unemployment or more likely to have
lower-skilled occupations compared to their siblings or the
general population (97–100). However, findings from Europe
are less conclusive with some reporting higher unemployment
rates among European survivors compared to the general
population (101–103), whereas others did not observe increased
unemployment rates (104–108).
Both unemployment and lower educational attainments
have a substantial impact on the survivors’ financial
situation, and survivors’ income has been shown to be
markedly lower compared to their siblings or the general
population (101, 108, 109).
Notably, survivors of CNS tumors, survivors treated with
cranial radiotherapy and those diagnosed at younger age
irrespective of cancer type, seem to be at particular risk of adverse
socioeconomic outcomes (90).
DISCUSSION ON UNDERLYING
MECHANISMS AND PATHWAYS OF
SOCIAL INEQUALITIES IN CHILDHOOD
CANCER
The underlying mechanisms and causal pathways of these
empirically demonstrated social inequalities along the childhood
cancer continuum are poorly understood. These mechanisms
are likely to differ from those for cancer in adults. For
instance, the well-documented relationship between SEP and
cancer survival in adults (2) is associated with differences
in the time of diagnosis, biological characteristics of the
tumor, treatments given and individual characteristics, such as
lifestyle or the presence of co-morbidities (3, 5, 110). However,
social inequalities in survival from childhood cancer would,
at least in most high-resource settings, not be expected to
be related to inequalities in co-morbidities, children’s lifestyle
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or treatment (as children have free and equal access to
health care services). Moreover, the implications of a cancer
diagnosis for later socioeconomic achievements, for instance
educational or occupational attainments, in survivors are likely
to differ substantially between childhood as compared to
adult cancer survivors, where a certain educational level and
occupational position has been reached by many patients prior
to cancer occurrence.
Understanding the mechanism and pathways leading to these
social inequities as well as understanding how a childhood cancer
diagnosis affects the socioeconomic situation of the family or
the later life of survivors is essential for actions and strategies to
tackling inequities.
Theoretical frameworks are helpful to promote understanding
and direct investigations on the social determinants of health and
health inequalities. There are many frameworks illustrating how
those determinants may operate and how they can be improved
to reduce social inequities in health (8, 111). However, to our
knowledge none of the existing frameworks is particularly suited
to elucidate underlying mechanisms and pathways of social
inequities in childhood cancer.
CONCEPTUAL MODEL
On the basis of the Commission on Social Determinants
of Health framework (8) we developed a conceptual model
(Figure 3) specifically addressing underlying mechanisms and
pathways of social inequities in childhood cancer and after
childhood cancer. The conceptual model aims to (i) illustrate
potential pathways by which social determinants may create
health inequities at different points of the childhood cancer
continuum; (ii) illustrate potential pathways by which a
childhood cancer diagnosis may impact the socioeconomic
situation of the concerned family or the later life of a childhood
cancer survivor; and (iii) point out how major determinants
relate to each other.
Our framework clearly distinguishes between social
determinants of childhood cancer—‘the social cause impacting
on the childhood cancer continuum’ vs. social determinants
of inequities in childhood cancer—‘the social conditions
determining the distribution of this social causes across social
groups’ (Figure 3). It thereby distinguishes between the
mechanisms by which social inequities are created and the
conditions of life which then result and impact directly on
health and well-being: this is the childhood cancer continuum
in our scenario (8). We consider the social determinants of
inequities in childhood cancer as structural determinants and
the social determinants of childhood cancer as intermediary
determinants (Figure 3).
Social Determinants of Inequities in
Childhood Cancer
In this conceptual model family social conditions are
understood in a broad sense, not solely encompassing traditional
characteristics such as education, income, and occupation but
also extending to health literacy, living and working conditions,
social networks, and resources as well as cultural background.
The Childhood Cancer Continuum
Childhood cancer and related social determinants are seen from
a temporal perspective along the course of disease. The childhood
cancer continuum is the horizontal axis for this framework and
depicts the course of childhood cancer—from disease-free period
through pre-clinical phase to diagnosis, established morbidity,
survivorship, and to the end of life.
Pathways of Social Inequities
Various different underlying mechanisms and pathways
including several external, intrinsic and cancer-related
determinants and a complex interplay of those are likely to
contribute to the empirically observed social inequities along the
childhood cancer continuum. Key pathways of social inequities
may travel from family social conditions through determinants
related to health and supportive care including access and
utilization of health care services, diagnosis, treatment,
supportive care as well as psychosocial aspects related to the
cancer diagnosis and its management. Moreover, important
associations might also exist with determinants unrelated to
health care, e.g., exposures to risk factors or the psychosocial
constitution and resources of the concerned family. Pathways
related to health and supportive care as well as psychosocial
aspects are solely affecting inequities in morbidity, survival
and survivorship, while social differences in the exposure to
risk factors affect the development of childhood cancers across
social groups.
As the drivers that influence childhood cancer occurrence are
different from those of inequities in survival and survivorship, so
are the underlying mechanisms and pathways they take likely to
differ. Similarly, the underlying mechanisms and pathways are
likely to vary substantially between types of childhood cancer
and related treatment duration and intensity, side effects, psycho-
social and socioeconomic impact on the family, as well as
late effects.
Incidence and Risk
The observed differences in the occurrence of some childhood
cancer types by socioeconomic group within a HIC are likely to
reflect differences in exposure to some environmental pollutants
or (parental) behavioral, biological, or genetic risk factors (41)
that vary by socioeconomic groups. This mechanism should
apply equally to HICs and LMICs, but how prevalent the
exposure is in each socioeconomic group may vary between
settings. Moreover, the social context is obviously of relevance for
the probability of getting diagnosed: some countries, particularly
in resource-poor settings, have large differences in access to,
utilization of and quality of health care services by SEP which is
likely to have resulted in under-diagnosis of cases (18, 23).
The underlying reasons for the observed geographical
differences in incidence rates between countries across the world
are not well-known. Differences in genetic or environmental
exposures that affect the risk of childhood cancers or certain
types may play a limited role. The high incidence rates of
Frontiers in Public Health | www.frontiersin.org 6 April 2019 | Volume 7 | Article 84
Erdmann et al. Social Inequalities in Childhood Cancer
FIGURE 3 | Conceptual model illustrating potential mechanisms and pathways of social inequities along the childhood cancer continuum.
Burkitt lymphoma, Hodgkin lymphoma and Kaposi sarcoma
in Sub-Saharan Africa (shown in Figure 1 for Uganda) are
related to the specific exposure to infectious diseases in that
region (namely Epstein-Barr virus, malaria, HIV, and human
herpes virus 8) (18, 112, 113). However, for some other cancer
types several recent reports indicate that under-diagnosis and
under-reporting of cancer cases, at least of leukemia and CNS
tumors, may be sufficiently large to account for the majority of
the observed differences between some LMICs compared with
Europe and North America (17, 26, 28, 114). The empirically
reported differences may thus ultimately be related to inequities
in access, utilization and quality of health care services including
“missed diagnosis” (22, 24, 25), high prevalence of other
infectious diseases (e.g., malaria, tuberculosis, HIV/AIDS), high
proportions of deaths from unknown causes and differences
in (childhood) cancer reporting standards (115). Registries in
LMICs are often facing substantial challenges with respect to
reporting information on cases and linkage between cancer
registries (if they exist); appropriate diagnostic and health care
facilities are not always in place or available only at central
level (18, 19, 116).
Diagnosis, Treatment, Supportive Care, and Survival
Underlying mechanisms and pathways of social inequities in
survival may be particularly complex and are likely to involve
multiple and potentially interacting determinants.
The large survival inequities observed globally between
countries by socioeconomic development are likely
predominantly related to limited access to (or utilization
of) health care services including contemporary therapy in
poor resource settings. Access and utilization are again related
to various determinants including poor financial resources,
poor organization of health care, poor public transportation
infrastructure, cultural beliefs (e.g., belief in traditional medicine)
as well as importantly limited access to first-line diagnostics
leading to lack or incorrect diagnosis and therapy. An unknown
but high proportion of children in LMICs with potentially
curable cancer never receives contemporary therapy or, may
even not be able to access basic health care services provided
by a trained oncologist (34, 117, 118). Primary healthcare
facilities and local/regional hospitals may lack awareness of and
experience in diagnosing pediatric cancer (18, 19, 114) and the
non-specific nature of many early symptoms for some cancer
types (e.g., leukemia which often presents with symptoms similar
to those of infections) may result in delayed diagnosis or failure
to detect the disease at all (34, 115). Even if a childhood cancer
is diagnosed, childhood cancers are complex diseases and risk
group adapted therapy is crucial (34, 119). Lack of access to
first-line diagnostics including pathology services, genetics and
high resolution imaging negatively influences outcomes (34).
Even when symptom clearly indicate that a child is suffering
from cancer, culture attitudes toward concealment of a cancer
in the family, nihilistic beliefs about its curability and trust
in traditional medicine may prevent or subsequently delay
diagnosis and contemporary therapy (18). Traditional medicine
and cultural beliefs continue to play an important role in
healthcare delivery in parts of Sub-Saharan Africa, particular
among the Black population (118, 120).
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Moreover, malnutrition, frequent treatment abandonment
or refusal of treatment, co-morbid infections (e.g., HIV) toxic
deaths and avoidable relapse are important contributing factors
(18, 19, 34, 117, 121, 122) to poor survival in LMICs.
Pathways of survival inequities within countries are likely
to vary substantially between countries and regions (such as
between high-resource and resource-poor countries) and type
of cancer. The pathways outlined in the previous paragraphs
concern mainly families with lower SEP in LMICs and apply
also to the observed inequalities with respect to low SEP inferior
survival in LMICs (53–57).
Underlying mechanisms which may play an important role
in HICs include delayed diagnosis in some social groups
(123), communication barriers with health care professionals
(124), differences in family’s social resources, demands and
health literacy (125) and parents’ and child’s adherence
to medication and treatment recommendations (61, 124).
Treatment adherence will have a greater effect upon outcome
in malignancies such as ALL (61, 126) for which outpatient oral
maintenance methotrexate/thiopurine therapy plays a major role
and treatment usually last several years (127). A study from the
UK revealed that socioeconomic differences in survival from
ALL emerged about 8–9 months after the diagnosis (61) which
is about the time when a child get typically discharged from
hospital and continuation of therapy requires parental/child’s
adherence (including daily drug intake and frequent outpatient
appointments). The authors hypothesized that this may be due to
treatment adherence (61). Besides treatment adherence, second-
line therapy might play an important role in survival difference
in HIC. If first-line therapy fails, there are rarely well-established
second-line therapies. The decision to treat with an intent to
cure reflects the attitude and the resources of both the physicians
and the family (128). SEP and in particular education may
play a significant role here, since aggressive second-line therapy
to obtain cure will reflect the family’s understanding of the
complexities and their ability to “co-decide” with the physician
to initiate such therapies.
However, although survival inequalities exist in HICs, most
children with poor socioeconomic SEP will still do substantially
better than the children with cancer with higher SEP in resource-
poor settings.
Family conditions are also found to be associated with
survival. However, the evidence is limited to observations in
HICs (58). Family factors are likely to play an important role
as children rely on their parents help and support, as well as
on the parents’ ability to observe and communicate conditions
of relevance for their child’s health and treatment to the health
care professionals. For some European populations (59, 60, 64,
69, 129, 130) the demands on families and their social resources
appear to be more or equally relevant as compared to the
socioeconomic situation of the family.
Socioeconomic Implications
In turn, social inequities may also be created or compounded
by the childhood cancer diagnosis. The empirically observed
socioeconomic implications on the parental situation are likely
to be related to the demanding caregiving, emotional, and
practical strains which parents with a sick child have to
handle (131). The child’s acute treatment requires frequent
hospitalizations, invasive procedures, and depending on the
cancer type, a combination of surgery, chemotherapy, or
radiotherapy (132). Managing the child’s disease and demanding
treatment alongside family and work-related responsibilities is
highly challenging. It may involve taking time off work, reducing
or entirely leaving paid employment, with subsequent income
reductions. Moreover, some parents reported elevated levels of
distress even years after the child’s acute treatment (133–135).
The complex interplay of the parents’ mental condition and
socioeconomic implications has hardly been studied so far, but
might also be an important underlying mechanism of adverse
socioeconomic implications.
The empirically observed groups of survivors at particular
risk of adverse socioeconomic outcomes—survivors of a
central nervous system tumor, survivors treated with cranial
radiotherapy and those diagnosed at younger age (90)—
give some indication for the underlying mechanisms of the
socioeconomic difficulties that some childhood cancer survivors
face in their later life. The most obvious pathway is related to
treatment and in particular radiation therapy received. Cranial
irradiation has been associated with a large number of somatic
late effects including long-term neurocognitive impairments,
including fatigue, vision or hearing deficits as well as problems
with concentration, learning and memory function (136–140).
Young age at cancer treatment might affect the growing
tissues and development with bones becoming deformed, tissue
fibrosis development and organ functions being impaired,
which may cause a large variety of morbidities and cognitive
impairments (136, 140, 141) and also lead to educational and
occupational difficulties.
However, socioeconomic difficulties in childhood cancer
survivors might not only relate to the childhood cancer treatment
itself, but also to the psychosocial stressors related to the disease
and its demanding treatment. Survivors are at increased risk
of mental conditions manifesting several years after the cancer
diagnosis and treatment (142, 143). Moreover, the ability of
the parents and care givers, the child with cancer and the
entire families to handle a stressor like a cancer diagnosis and
the availability of internal and external resistance resources,
such as cognitive skills, management of emotional distress, and
social support, may influence the socioeconomic situation of
the childhood cancer survivors, also in a long-term perspective
(90, 144, 145). Further, absence from school during the active
treatment period may cause difficulties with reaching similar
educational accomplishments as their peers and educational
delays (146). How well a family is able to make up for
absence from school might be related to the family social
resources as well as to the parent’s socioeconomic background.
Somatic late effects and educational difficulties may limit the
ability to work or to attain higher occupational positions, with
subsequent lower opportunities to reach higher income levels
and independence from social security benefits (90). Finally,
some national legislation and policies might contribute to the
socioeconomic difficulties of childhood cancer survivors. In some
countries childhood survivors are not sufficiently protected from
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discrimination and finical disadvantages, including equal access
to loans and insurances (147).
CONCLUSION
The underlying mechanisms and pathways of the empirically
demonstrated social inequalities along the childhood cancer
continuum are poorly understood. We developed a conceptual
framework specifically on social inequities in childhood
cancer postulating mechanisms and pathways by which social
determinants may create health inequalities and point out how
major determinants relate to each other. Important identified
and hypothesized underlying mechanisms and pathways of
social inequity along the childhood cancer continuum which
could be targets of future interventions and policy strategies to
reduce childhood cancer-related inequity include timely and
equal access to first-line diagnostics, contemporary therapy
and supportive care, social support for families with a child
with cancer, long-term follow-up of vulnerable groups of
childhood cancer survivors to identify early signs of somatic
and psychiatric late effects and adverse socioeconomic or
psychosocial conditions, as well as a legal framework to protect
cancer patients, survivors and their families from discrimination.
As an enhancement to previous conceptual frameworks, our
framework takes the course of childhood cancer into account
and stresses that each phase of the childhood cancer continuum
is influenced by varying social determinants. Moreover, our
framework distinguishes between social determinants of
inequities in childhood cancer and social determinants of
childhood cancer and thereby point toward the mechanisms
by which social inequities are created and the determinants
which impact directly on the childhood cancer continuum.
The framework aims to be comprehensive and should be
applicable to social inequities in childhood cancer on a
global scale.
Although the proposed mechanisms and pathways are
based on the best available scientific evidence, some are
rather speculative than evidence-based. We understand this
conceptual framework as work in progress which is thought
to identify research gaps and help directing scientific research.
Nevertheless, it may already be useful to identify potential
targets for tailored approaches and better policy making,
thus tackling social inequalities in childhood cancer and
enhance equity.
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